Allero Therapeutics is a Dutch biotech company that develops next generation immunotherapies for immune mediated disorders. Our goal is to develop novel targeted treatments that induce long-lasting antigen-specific tolerance.
Our proprietary SOMIT (Specific Oromucosal Immunotherapy) technology combines a tolerance-inducing agent with novel oral patch mediated targeted delivery of specific antigens to the oral mucosa immune privilege.
Company Details
- Employees
- 5
- Founded
- -
- Address
- Rotterdam Science Tower, Rotterdam,3029,netherlands
- in****@****ics.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Immunotherapy, celiac diseases, allergy, autoimmune diseases, covid-19, ARDS, food allergy.
- HQ
- Rotterdam
Allero Therapeutics Bv Questions
Allero Therapeutics Bv's website is http://www.allerotherapeutics.com
Allero Therapeutics Bv's LinkedIn profile is https://nl.linkedin.com/company/allero-therapeutics
Allero Therapeutics Bv has
5 employees.
View email and phone details for 5
employees at Allero Therapeutics Bv.
Allero Therapeutics Bv's industry is
Biotechnology Research
Allero Therapeutics Bv's top competitors are
Cinclus Pharma,
Leti Pharma,
Cytovation,
Nectin Therapeutics,
Alk,
Batavia Biosciences,
Fibriant Bv,
Vb Devices,
Argobio Studio,
Cenexum.
Allero Therapeutics Bv's support email address is info@allerotherapeutics.com
Allero Therapeutics Bv's categories are Biotechnology Research
Allero Therapeutics Bv's founding year is 2019
